Search for:

Home
About
Where we work
News
Strategies
Resources

Resources

Access Granted

A budget advocacy toolkit for improving access to quality and affordable medicines through Global Fund grants.

Best practices and models Resource

Download (pdf 3.23 MB)

Keep in Touch

Our email newsletter has latest news on developments and campaign actions

Subscribe to our mailing list

Twitter

RT @GlobalJusticeUK: "I joined this research trial out of solidarity and a belief in the common good. But I'm worried that this publicly-fu…
5 days ago

Make Medicines Affordable Twitter

Facebook

Russian NGOs have opposed Gilead's patent on Truvada (TDF/FTC), recommended for HIV treatment, and as PrEP.
Russia pays around 40x more for Gilead's overpriced branded version: $200 per month, compared to $5 per month for quality-assured generic versions.
If the court revokes the patent it will save money and lives.
The next hearing is September 2020.
makemedicinesaffordable.org/russian-ngos-oppose-gileads-patent-for-hiv-drug-truvada/ ... See MoreSee Less

5 days ago ·

ITPC global Facebook

© Copyright ITPC 2020 Cookies Contact us

Website by Maraid Design